Neurodiagnostics Market Overview
Neurodiagnostics is the study of brain by recording electrical activity in central nervous system, brain and peripheral nervous system. Neurodiagnostics lab provides diagnostic investigations to aid physicians in determining, diagnosis & treatment of stroke, epilepsy, neuromuscular, Parkinson disease, & other neurological diseases. Neurodiagnostic technology has become important in determining brain dead and hidden cause of mental disorders. Electroencephalogram (EEG) test used in diagnosing nerves and brain related conditions like dizziness and headache. Mental status, determination of nerves of brain, sensory exam, co-ordination exam, reflexes in older child & adults, newborn & infant reflexes, are checked during neurological exam. Memory loss, headache, lack of co-ordination, loss of tingling, persistent or sudden headache, loss of sight are some of the symptoms of nervous system disorders. Magnetic Resonance Imaging is used in diagnosis of stroke, brain & spinal cord tumors, traumatic brain injury, vascular irregularities, brain damage with epilepsy, infection, inflammation, etc. Stroke is the severe neurological disorder. Skin biopsy, autonomic function test, diagnosing peripheral neuropathy, blood tests, electromyography, used in detecting nerve damage. Genetic disorders, infections, unhealthy lifestyle, malnutrition, spinal cord injury, brain injury, nerve injury, are some causes of neurological disorders. Anxiety and chronic stress lead to structural degeneration and impaired functioning of hippocampus which increase the risk of neuropsychiatric disorder like dementia and depression. Medication therapy is the common treatment for neurological conditions like traumatic brain injury, stroke and others. Positive emission tomography (PET), magnetic resonance imaging (MRI), and computed tomography (CT) are major types of brain scan for detecting neurological disorders. Rise in prevalence of neurological diseases has given positive impact on Neurodiagnostics market growth.
Neurodiagnostics Market Dynamics
Rise in prevalence of neurological diseases, and rate of urbanization
Rise in prevalence of neurological diseases and rate of urbanization is one of the leading factors for the Neurodiagnostics Market growth. Urbanization has given rise in consumption of western food, processed food, frozen packed foods, which are unhealthy and affect the health of human being. Urbanization has caused change in diet. Eating processed and unhealthy food affect the health causing chronic disease like heart disease, diabetes, obesity, high blood pressure, etc. Stress and anxiety are main causes of neurological disorders. Urban living has caused adverse effects on mental health. Risk of developing depression, anxiety is rising due to alone living, lack of communication, excess use of social media, increase in performance pressure at work in today’s competitive age. Migration to cities has increased rapidly. Children and women are vulnerable to interpersonal violence in urban areas, developing countries which has led to rise in depression and dementia. WHO (World Health Organization) has determined the higher prevalence of mental disorders in urban areas than in rural areas. According to data published by United Nations in 2018, about 55% of the world’s population resided in urban areas, and it is projected that this percentage will increase over the forecast period. However, the growth in prevalence of neurological diseases and population in urban areas boosts the demand for Neurodiagnostics market.
Technological advancement
Recent technological advancement in neurodiagnostics has become the major factor in target market growth. Advancement in diagnostic technology has revolutionized the field of neurology. Newly advanced EEG (Electroencephalogram) device has opened new possibilities which makes easy and quick scan of brain. Electrodes and newly advanced EEG hardware are wireless electrodes, low cost, and easy to use. Ubiquitous electronic health records helps in gathering and storing information. Advancement in artificial intelligence and machine learning helps in finding patterns of complicated data EEG generated recordings. Ultrasound technology and magnetic resonance technology is used in treating tremors in patients who are not responded to medications. CT (computed tomography) is superior to MRI (magnetic resonance imaging) used in visualizing fine bone detail in posterior fossa, spinal canal and base of skull. Computed tomography provides rapid and non-invasive imaging of skull and brain. However, technological advancement has fueled the neurodiagnostics market growth.
Restrains:
However, high cost in diagnosis and lack of skilled expertise may somewhat restrain the neurodiagnostics market growth.
Neurodiagnostics Market Segmentation
Neurodiagnostics Market is segmented based on type, end-users and region.
Type Insight
On the basis of Type Neurodiagnostics Market is segmented into In-vitro Diagnostics, Imaging Systems, Molecular Diagnostics, Computed Tomography (CT), Electroencephalogram Systems, and others. Electroencephalogram Systems has dominated the target market due to its technological advancement and wide applications in diagnosis of sleep disorders, brain death, depth of anesthesia, cerebral hypoxia, and encephalopathies.
End-Users Insights
On the basis of End-Users Neurodiagnostics Market is segmented into Hospitals, Clinics, Diagnostic Laboratories, Research Laboratories, Neurology Centers, Surgery Centers, and others. Diagnostic Laboratories has dominated the target market growth due to its advancement in diagnostic equipment, and it provides accurate, meaningful and precise routine measurement which are essential for diagnosis.
Regional Insights:
On region the Neurodiagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements. Moreover, rising prevalence of neurological disorders, high disposable income, high spending in healthcare due to awareness about health in an individual, and development of robust healthcare infrastructure is anticipated to increase demand for Neurodiagnostics in the region.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2022 |
|
Forecast period |
2022 – 2032 |
|
Market representation |
Revenue in USD Billion & CAGR from 2022 to 2032 |
|
Market Segmentation |
By Type - In-vitro Diagnostics, Imaging Systems, Molecular Diagnostics, Computed Tomography (CT), Electroencephalogram Systems, and others By End-Users - Hospitals, Clinics, Diagnostic Laboratories, Research Laboratories, Neurology Centers, Surgery Centers, and others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Neurodiagnostics Market report based on type, end-users and region:
Neurodiagnostics Market, By Type:
- In-vitro Diagnostics
- Imaging Systems
- Molecular Diagnostics
- Computed Tomography (CT)
- Electroencephalogram Systems
- Others
Neurodiagnostics Market, By End-Users:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Research Laboratories
- Neurology Centers
- Surgery Centers
- Others
Neurodiagnostics Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Neurodiagnostics Market Key Players
The key players operating the Neurodiagnostics Market includes,
- GE Healthcare
GE Healthcare is headquartered in Chicago, Illinois. GE Healthcare is manufacturer, and distributor of radiopharmaceuticals, diagnostic imaging agents, and medical diagnostic equipment like MRI (magnetic resonance imaging), CT image machines, ultrasound, X-ray, mammogram, cath labs, nuclear medicine cameres and others.
- Thermo Fisher Scientific Inc.
Thermo Fisher Scientific is an American supplier of reagents and consumables, scientific instrumentation, and software services. Thermo Fisher Scientific provides clinical trial logistics, commercial manufacturing and industry leading pharmaceutical services & solutions for drug development.
- Siemens Healthineers
Siemens Healthineers is a German medical device company. Siemens Healthineers is the market leader in diagnostic imaging for molecular imaging, magnetic resonance imaging and computed tomography. Siemens Healthineers also offers products like ultrasound systems, X-ray products and imaging IT.
- Hoffman La Roche AG
Hoffman La Roche is a Swiss multinational healthcare company that develops drugs & diagnostics in treating major diseases. Hoffman La Roche provides a medicinal treatment for cancer, infectious diseases, central nervous system disorder, respiratory diseases, and auto-immune diseases.
- Mitsar Co. Ltd.
Mitsar Co. Ltd., is located at Saint Petersburg. Mitsar is developer of medical devices used for scientific research and functional diagnostics. Mitsar is the leading manufacturing company in medical equipment for neurophysiology and functional diagnostics. Mitsar also offers products like ambulatory EEG solutions, Mitsar-EEG electroencephalographs, wearable wireless EEG systems for research and others.
- QIAGEN
QIAGEN is a biotechnology company which is headquartered in Venlo, Netherlands. QIAGEN is the leading provider of assay technology and samples used in molecular diagnostics, academic & pharmaceutical research, and applied testing. QIAGEN offers products in healthcare, biotechnology, food safety, life science, veterinary practices, pharmaceutical, forensics and others.
- Canon Inc.
Canon Inc., is Japanese multinational company which is headquartered in Ota, Tokyo, Japan. Canon is specialized in optical imaging, scanners, medical equipment, cameras, lenses, and others. Canon is a leading provider of business-business, consumer, industrial digital imaging solutions to U.S. and other markets.
- Philips Healthcare
Philips Healthcare is headquartered in Best, Netherlands and Andover, Massachusetts, U.S. Philips Healthcare provides healthcare solutions in treatment, diagnostic and preventive care. Philips Healthcare offers computed tomography, advanced molecular imaging and customer service solutions.
- Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, is an American developer and manufacturer of specialized technological products for clinical diagnostic market and life science research. Bio-Rad Laboratories offer products like software, instruments, reagents, consumable products, in areas like drug discovery & manufacture, cell biology, food safety, protein purification and gene expression.
- Combinostics
Combinostics, is headquartered in Tampere, Finland. Combinostics offer solutions in early detection, management and diagnosis of major neurological disorders. Combinostics provides cloud based tools for extraction of biomarkers from images, cognitive tests and lab data & integrating and contrasting all data from patients who are previously diagnosed.
Recent Development:
- In June 2022, Combinostics has launched new latest version of its ‘cNeuro Platform’ to cNeuro 2.1.0 which includes, cDSI and cMRI applications. Newly launched version will help in supporting radiologists by providing complete automated detection, reporting abnormalities on brain MRI and also provides clinical decision support system by combination of imaging information with all other data of patients for neurologists.
Neurodiagnostics Market Company Profile
- Combinostics*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- GE Healthcare
- Thermo Fisher Scientific Inc.
- Siemens Healthineers
- Hoffman La Roche AG
- Mitsar Co. Ltd.
- QIAGEN
- Canon Inc.
- Philips Healthcare
- Bio-Rad Laboratories Inc.
“*” marked represents similar segmentation in other categories in the respective section
Neurodiagnostics Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By End-Users
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Neurodiagnostics Market, By Type
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- In-vitro Diagnostics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Imaging Systems
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Molecular Diagnostics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Computed Tomography (CT)
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
-
- Electroencephalogram Systems
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Electroencephalogram Systems
- Neurodiagnostics Market, By End-Users, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Clinics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Diagnostic Laboratories
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Research Laboratories
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Neurology Centers
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Surgery Centers
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Others
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2022 – 2032
- Overview
- Neurodiagnostics Market, By Region, 2022 – 2032, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), 2022 – 2032
- Y-o-Y Growth Analysis (%), 2022 – 2032
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Type, 2022 – 2032
- Market Size and Forecast (US$ Bn), By End-Users, 2022 – 2032
- Market Size and Forecast (US$ Bn), By Country, 2022 – 2032
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- GE Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Siemens Healthineers
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Hoffman La Roche AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Mitsar Co. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- QIAGEN
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Canon Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Philips Healthcare
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bio-Rad Laboratories Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Combinostics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Neurodiagnostics Market is segmented into type, end-users and region.
Neurodiagnostics Market is driven by factors like rise in prevalence of neurological diseases, rate of urbanization, and technological advancement.
By region, the Neurodiagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period, owing to growing population, especially in countries such as Europe and Asia Pacific, and technological advancements.
The key players operating the Neurodiagnostics Market includes, GE Healthcare, Thermo Fisher Scientific Inc., Siemens Healthineers, Hoffman La Roche AG, Mitsar Co. Ltd., QIAGEN, Canon Inc., Philips Healthcare, Bio-Rad Laboratories Inc., Combinostics, and others.